ElixMD: Board-Certified Providers Review Every Intake Individually
Licensed physicians and nurse practitioners assess your complete health profile before any prescription is issued. No automated approvals. No shortcuts. Just real clinical care — fully online.
Start My Intake at ElixMD →- BMI — threshold of 30+ or 27+ with a qualifying health condition.
- Medical history — specifically thyroid cancer history and pancreatitis (absolute contraindications).
- Current medications — for interactions, especially with insulin and diabetes drugs.
- Lab work — metabolic panel, HbA1c, thyroid, and lipids (varies by program).
- Pregnancy and breastfeeding status — confirmed before any prescription is written.
The Six Categories of a GLP-1 Clinical Review
Every thorough GLP-1 clinical review covers six distinct categories of information. Together they tell your provider whether you are eligible, whether treatment is safe, and what the right starting approach looks like for your specific situation.
Why the Thyroid History Question Matters So Much
Of all the history questions in a GLP-1 intake, the thyroid cancer question is the one where accuracy is most clinically consequential. Here is why providers take it so seriously — and why you should answer it precisely.
GLP-1 and Thyroid C-Cell Tumors — What the Evidence Says
GLP-1 receptor agonists carry an FDA boxed warning — the most serious safety warning category — regarding thyroid C-cell tumors. In rodent studies, GLP-1 receptor agonists caused C-cell hyperplasia and thyroid tumors. The clinical relevance in humans is less clear — no direct causal link has been established in human trials — but the mechanistic concern is sufficient to establish:
- Absolute contraindication: personal or family history of medullary thyroid carcinoma (MTC) — the specific type of thyroid cancer involving C-cells
- Absolute contraindication: personal or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN2), a genetic syndrome that includes MTC as a component
- Not a contraindication: hypothyroidism, hyperthyroidism, Hashimoto's disease, or other thyroid conditions that do not involve MTC or MEN2
- Not a contraindication: a family history of papillary or follicular thyroid cancer — only the medullary subtype triggers the contraindication
When your intake asks about thyroid history, it is specifically looking for MTC and MEN2 — not thyroid conditions broadly. Answering "yes, I have thyroid issues" when you mean "I have Hashimoto's" creates unnecessary clinical confusion. Being specific — naming your condition — is the most helpful approach.
Pancreatitis history is the other major red-flag question in any GLP-1 intake. GLP-1 medications have been associated with increased pancreatic inflammation in some studies, making active pancreatitis or a recent history of pancreatitis a strong contraindication. A distant history of a single mild episode may be evaluated on a case-by-case basis — but chronic or recurrent pancreatitis is typically disqualifying. If you have had any pancreatic issues, disclose them specifically and let your provider make the clinical determination.
The Lab Work Review — What Each Test Tells Your Provider
Lab work is not bureaucracy — each panel tells your provider something specific about whether GLP-1 is safe and appropriate for you, and how to calibrate your starting approach.
Comprehensive Metabolic Panel (CMP)
Assesses kidney function (creatinine, BUN), liver function (ALT, AST), electrolytes, and fasting blood glucose. Kidney and liver impairment can affect medication clearance. Elevated glucose at baseline establishes whether diabetes management is a component of treatment.
HbA1c (Glycated Hemoglobin)
Reflects average blood sugar over the past 2–3 months. Identifies undiagnosed prediabetes or type 2 diabetes, confirms the qualifying condition if applicable, and establishes a metabolic baseline for tracking improvement during treatment.
Thyroid Panel (TSH)
Establishes thyroid function baseline before starting GLP-1. Uncontrolled hypothyroidism can contribute to weight gain independently of other factors — identifying it before starting GLP-1 allows for appropriate management and realistic expectations about treatment response.
Lipid Panel
Total cholesterol, LDL, HDL, and triglycerides. Establishes cardiovascular risk profile baseline and confirms dyslipidemia as a qualifying condition if applicable. GLP-1 treatment typically improves lipid profiles — tracking this change is clinically meaningful throughout treatment.
If you have had bloodwork in the past 6–12 months through your primary care doctor, your employer's health screening, or any other source — gather those results before starting your intake. Most telehealth programs accept recent lab results uploaded through the patient portal, eliminating the need for a separate lab visit and shaving 3–5 days off your time to first prescription.
Medication Interactions — What Providers Specifically Look For
Your medication list is not just a data-collection formality — it is an active clinical safety screen. Here is what providers are specifically watching for when they review your medications.
The Medications That Require Careful Review Before GLP-1
- Insulin: GLP-1 and insulin together significantly increase hypoglycemia (low blood sugar) risk. If you take insulin, your provider will likely recommend a dose reduction — often 20% — before starting GLP-1, with close monitoring during the adjustment period.
- Sulfonylureas (glipizide, glimepiride, glyburide): insulin secretagogues that, like insulin, increase hypoglycemia risk when combined with GLP-1. Dose adjustment is typically required.
- Oral medications with narrow therapeutic windows: GLP-1 slows gastric emptying, which delays the absorption of oral medications. For drugs where precise timing and absorption matter — certain thyroid medications, some antibiotics, specific cardiovascular drugs — your provider evaluates whether this interaction requires dose adjustment or timing changes.
- Warfarin and other anticoagulants: GLP-1 can affect the absorption and thus the efficacy of anticoagulants. Providers typically recommend closer INR monitoring during GLP-1 initiation for patients on warfarin.
- Oral contraceptives: delayed gastric emptying can theoretically affect OCP absorption timing. Your provider will note this and may recommend back-up contraception during the first month of GLP-1 use.
The medication review is only as accurate as what you disclose. Include all prescription medications, OTC drugs (including NSAIDs, antacids, and sleep aids), supplements, vitamins, and herbal remedies. Some supplements — particularly those affecting blood sugar like berberine or chromium — have relevant interactions with GLP-1 that providers need to know about. "It's just a supplement" is not a reason to omit it.
What Your Provider Decides After the Review
The clinical review produces one of three outcomes — and understanding all three helps you know what to do in each scenario.
Approved — Treatment Can Begin
You meet the eligibility criteria, have no disqualifying contraindications, and your lab work (if reviewed) supports safe treatment initiation. Your prescription is issued, sent to the pharmacy, and your medication ships within days. This is the outcome for the majority of women who complete a thorough intake accurately.
More Information Needed — Review Continues
Your provider has questions before making a determination. Common reasons: an incomplete intake that left important questions unanswered, a health history that requires clarification (a thyroid condition that needs more specificity), missing lab work that the program requires, or a medication interaction that needs to be discussed before proceeding. This is not a denial — it is a step in the process. Responding quickly and thoroughly to your provider's questions moves you toward approval.
Not a Candidate — With an Explanation
A small subset of applicants are not appropriate candidates for GLP-1 — due to absolute contraindications (thyroid cancer history, MEN2, active pancreatitis), below-threshold BMI, current pregnancy, or other clinical factors. A legitimate program explains the specific reason for the determination. This outcome, while disappointing, reflects a genuine clinical review — exactly what a trustworthy program should conduct.
How to Prepare for the Fastest, Smoothest Review
Women who complete their intake thoroughly and arrive prepared consistently move from intake to prescription faster — not because the clinical standards are lower, but because they eliminate the back-and-forth that slows most delayed approvals.
-
01
Complete medication list with dosages — prescription drugs, OTC medications, supplements, vitamins. Include the condition each medication treats and how long you have been taking it. Providers need the complete picture, not a summary.
-
02
Accurate current weight — weigh yourself on a reliable scale before starting. Your BMI calculation depends on this number — an inaccurate weight creates an inaccurate eligibility picture.
-
03
Specific health history details — not "I have some thyroid stuff" but "I have Hashimoto's hypothyroidism diagnosed in 2018, currently managed with levothyroxine 75mcg." Specificity eliminates follow-up questions.
-
04
Family health history for key conditions — specifically thyroid cancer (and the type), MEN2 syndrome, pancreatitis, and cardiovascular disease. These are the family history items that directly affect prescribing decisions.
-
05
Recent lab results if available — CMP, HbA1c, TSH, and lipid panel from the past 6–12 months. Upload these when prompted rather than waiting to be asked — it proactively eliminates the lab visit step.
-
06
Previous weight loss history — what you have tried, for how long, what results you achieved. Particularly relevant if your BMI is in the 27–29.9 range and you need to establish a qualifying condition alongside the weight management history.
"The intake is a clinical document, not a form. The women who get approved fastest are not the most eligible — they are the most prepared. Accuracy and specificity in the intake eliminate almost every source of delay."
— HauteFlair Women's Health Editorial Team
How to Identify a Real Clinical Review vs. a Rubber Stamp
| Indicator | Real Clinical Review | Rubber Stamp Process |
|---|---|---|
| Thyroid history question | Specifically asks about MTC and MEN2 | Generic "any thyroid conditions?" or skipped entirely |
| Pancreatitis screening | Directly asks about pancreatitis history | Not asked or buried in generic "serious conditions" list |
| Medication review | Full medication list requested and reviewed | Optional field or no medication review at all |
| Approval timeline | 24–48 hours — human review takes time | Instant approval — no human could review in seconds |
| Outcome for ineligible applicants | Some applicants are declined with explanation | Everyone is approved regardless of contraindications |
| Follow-up questions | Provider asks for clarification on unclear history | No follow-up — approval regardless of ambiguities |
What This Means for You
Understanding what providers look for before prescribing GLP-1 gives you two practical advantages. First, you can prepare for your intake in a way that makes the review faster and smoother — gathering the right information before you sit down to fill out the form, not after your provider asks follow-up questions. Second, you can identify whether a program is conducting a genuine clinical review or offering convenience at the cost of clinical rigor.
A thorough review that takes 24–48 hours and occasionally asks for clarification is a feature — not an inconvenience. It is the evidence that the program takes your safety as seriously as it takes your enrollment. The programs worth trusting are the ones where not everyone gets approved.
If you are ready to start, gathering your medication list, recent lab work, and specific health history details before opening the intake form is the most useful preparation you can do. It turns a 48-hour process into a straightforward one — and puts your first dose as close as possible to the start line.
Frequently Asked Questions
What do doctors look for before prescribing GLP-1?
What labs are required before starting GLP-1?
Can GLP-1 be prescribed without a full medical history?
Do you need to have tried other weight loss methods before getting GLP-1?
What medications interact with GLP-1?
Why do providers ask about thyroid history before GLP-1?
How long does the GLP-1 clinical review take?
This article is for informational purposes only and does not constitute medical advice. Eligibility determinations are made by licensed providers based on individual health profiles. Clinical review criteria may vary between programs and providers. Always verify credentials and review processes before enrolling in any GLP-1 telehealth program. ElixMD is an independent telehealth service; HauteFlair is not responsible for medical outcomes. This article contains affiliate links to ElixMD.
